Made from the north Queensland’s blushwood tree berries, QBiotics breakthrough cancer fighting EBC-46 drug for solid tumours has just received ethical approval for human trials.
Until now, EBC-46 has been administered through veterinary clinics with demonstrations on TV tonight showing it's effects on dogs.
Sound familiar?
CDY has a product that produces better results on cancer then chemotherapy & in vetrinary testing (Zoetis in CDY's case).
I see CDY's IP as having an advantage in that it will target small cancers that are not yet discovered to be injected with a syringe.
Between this & CDY's recent results reversing osteoporosis, there should be a little more international & big pharma attention on small ozzie bio.
- Forums
- ASX - By Stock
- AN1
- QBiotics v Cellmid
QBiotics v Cellmid
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable